[APLS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
02-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -14.40%
YoY- -94.34%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 623 0 250,000 646 0 0 -142 -
PBT -219,191 -183,659 80,110 -135,700 -118,617 -168,822 -113,217 55.39%
Tax 3,706 5,719 2 9,483 6,914 3,933 3,981 -4.66%
NP -219,191 -183,659 78,265 -135,700 -118,617 -168,822 -113,217 55.39%
Tax Rate - - -0.00% - - - - -
Total Cost 219,814 183,659 171,735 136,346 118,617 168,822 113,075 55.82%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -35,183.15 0.00 31.31 -21,006.19 0.00 0.00 79,646.45 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -2.72 -2.32 0.99 -1.79 -1.57 -2.29 -1.54 46.16%
EPS Diluted -2.72 -2.32 0.99 -1.79 -1.57 -2.29 -1.54 46.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.